BioCentury | Jul 13, 2015
Company News

Synthetic Genomics, Gen9 deal

...of patents and patent applications covering genomic technologies, including the methods licensed to Gen9, from Febit...
BioCentury | Sep 24, 2012
Finance

Hopp stays the course

...brain cancer Comprehensive Biomarker Center GmbH Germany Molecular diagnostics 2005 55% 75% Changed name from febit group...
BioCentury | Sep 24, 2012
Company News

Comprehensive Biomarker Center, Synthetic Genomics deal

Febit Holding GmbH, part of Comprehensive Biomarker Center, granted Synthetic Genomics worldwide rights to three families of patent and patent applications covering genomic technologies. The methods covered include parallelized, low-cost oligonucleotide synthesis and retrieval of...
BioCentury | Jun 28, 2010
Company News

febit microarrays news

...headcount by about 60% to 30-35 to focus on its blood-based microRNA biomarker discovery services. febit...
...its Heidelberg, Germany location. As part of the restructuring, President and CEO Cord Staehler resigned. febit...
...Kohlhaas, will serve as co-CEOs. Voss is currently CBO at Life Biosystems GmbH (Basel, Switzerland). febit group...
BioCentury | Oct 26, 2009
Clinical News

Geniom Real Time Analyzer: Postmarketing study data

...samples from 20 RRMS patients and 19 healthy volunteers. Data were published in PLoS one. febit group...
BioCentury | Oct 26, 2009
Clinical News

Geniom Real Time Analyzer: Postmarketing study data

...samples from 17 NSCLC patients and 19 healthy volunteers. Data were published in BMC Cancer. febit group...
BioCentury | Oct 5, 2009
Company News

febit, Life Technologies sales and marketing update

...The companies will co-market febit's HybSelect sequence capture technology and Life Technologies' Applied Biosystems SOLiD high...
...Biosystems SOLiD high throughput sequencing system. The systems can be used together for targeted sequencing. febit group...
BioCentury | Jul 6, 2009
Company News

febit sales and marketing update

...febit launched a biochip covering the whole mouse genome for profiling genes and SNPs. febit group...
BioCentury | Jan 26, 2009
Company News

febit management update

febit group , Heidelberg, Germany Business: Microarrays Hired: Heinz Blunier as COO, formerly head of the engineering department at Inventa AG WIR Staff...
BioCentury | Apr 7, 2008
Company News

febit biotech GmbH scientific advisory board update

febit biotech GmbH , Heidelberg, Germany Business: Microarrays Appointed: Mark Chee, co-founder of Illumina Inc. , as chairman; Karoly Nikolich, former executive director of the Neuroscience Institute at Stanford University, as vice chairman; David Lockhart, CSO of...
Items per page:
1 - 10 of 33
BioCentury | Jul 13, 2015
Company News

Synthetic Genomics, Gen9 deal

...of patents and patent applications covering genomic technologies, including the methods licensed to Gen9, from Febit...
BioCentury | Sep 24, 2012
Finance

Hopp stays the course

...brain cancer Comprehensive Biomarker Center GmbH Germany Molecular diagnostics 2005 55% 75% Changed name from febit group...
BioCentury | Sep 24, 2012
Company News

Comprehensive Biomarker Center, Synthetic Genomics deal

Febit Holding GmbH, part of Comprehensive Biomarker Center, granted Synthetic Genomics worldwide rights to three families of patent and patent applications covering genomic technologies. The methods covered include parallelized, low-cost oligonucleotide synthesis and retrieval of...
BioCentury | Jun 28, 2010
Company News

febit microarrays news

...headcount by about 60% to 30-35 to focus on its blood-based microRNA biomarker discovery services. febit...
...its Heidelberg, Germany location. As part of the restructuring, President and CEO Cord Staehler resigned. febit...
...Kohlhaas, will serve as co-CEOs. Voss is currently CBO at Life Biosystems GmbH (Basel, Switzerland). febit group...
BioCentury | Oct 26, 2009
Clinical News

Geniom Real Time Analyzer: Postmarketing study data

...samples from 20 RRMS patients and 19 healthy volunteers. Data were published in PLoS one. febit group...
BioCentury | Oct 26, 2009
Clinical News

Geniom Real Time Analyzer: Postmarketing study data

...samples from 17 NSCLC patients and 19 healthy volunteers. Data were published in BMC Cancer. febit group...
BioCentury | Oct 5, 2009
Company News

febit, Life Technologies sales and marketing update

...The companies will co-market febit's HybSelect sequence capture technology and Life Technologies' Applied Biosystems SOLiD high...
...Biosystems SOLiD high throughput sequencing system. The systems can be used together for targeted sequencing. febit group...
BioCentury | Jul 6, 2009
Company News

febit sales and marketing update

...febit launched a biochip covering the whole mouse genome for profiling genes and SNPs. febit group...
BioCentury | Jan 26, 2009
Company News

febit management update

febit group , Heidelberg, Germany Business: Microarrays Hired: Heinz Blunier as COO, formerly head of the engineering department at Inventa AG WIR Staff...
BioCentury | Apr 7, 2008
Company News

febit biotech GmbH scientific advisory board update

febit biotech GmbH , Heidelberg, Germany Business: Microarrays Appointed: Mark Chee, co-founder of Illumina Inc. , as chairman; Karoly Nikolich, former executive director of the Neuroscience Institute at Stanford University, as vice chairman; David Lockhart, CSO of...
Items per page:
1 - 10 of 33